Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Published October 15, 2025 · Recall initiated: September 22, 2025
Summary
FDA records drug Class II recall D-0003-2026, published October 15, 2025 and initiated September 22, 2025. Recalling firm: RC Outsourcing, LLC; Status: Terminated; Reported quantity: 2,669 syringes; Lot: Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RC Outsourcing, LLC
- Distributor
- Nationwide in the US
- Lot
- Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAWyandotte, Sanifect E3, Hand Sanitizer (Ethanol-Based, Product 5511), Ethyl Alcohol 60.1%, Manufacture By:October 15, 2025
- FDAAFCO, Hand Sanitizer (Isopropyl Alcohol-Based, Product 5515), Manufactured by: AFCO, 550 Development Avenue,October 15, 2025
- FDALevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for AccordOctober 15, 2025
- FDAArgus PB-3000, Reference Numbers: 1A.701307,3.921002, 3.921030,3.921031, 3.921006October 8, 2025
- FDAMAGNETOM Verio. Model Number: 10276755.October 8, 2025
- FDAMAGNETOM Skyra (DE). Model Number: 10432915. 510(k) Numbers: K101347, K111242, K123510, K133435, K140253,October 8, 2025
Questions about this recall
Was Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436. recalled?
Yes. FDA published recall D-0003-2026 on October 15, 2025. Reported hazard: Lack of assurance of sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter